Table 4B.
Association with ICU admission (logistic regression separately for SARS-CoV-2 positive patients and SAB).
| SARS-CoV-2 positive | SAB | |||
|---|---|---|---|---|
| OR (95% CI) | p-value | OR (95% CI) | p-value | |
| Female vs male | 0.55 (0.16, 1.91) | 0.349 | 2.81 (0.80, 9.92) | 0.108 |
| Age (increase of 1 year) | 1.02 (0.98, 1.05) | 0.364 | 1.01 (0.97, 1.04) | 0.625 |
| CCI, median (IQR) | 0.90 (0.59, 1.39) | 0.641 | 0.93 (0.68, 1.27) | 0.652 |
| WCC, median (IQR) | 0.99 (0.92, 1.07) | 0.879 | 0.96 (0.86 1.7) | 0.437 |
| Neutrophils, median (IQR) | 1.15 (0.94, 1.41) | 0.163 | 0.96 (0.86, 1.08) | 0.505 |
| CRP (increase for 10 units), median (IQR) |
1.13 (1.03, 1.23) | 0.008 | 1.06 (1.00, 1.12) | 0.034 |
| IL-6 (increase for 10 units), median (IQR) | 0.95 (0.87, 1.03) | 0.232 | 1.07 (1.02, 1.12) | 0.01 |
CCI, Charlson comorbidity index; CRP, C-reactive protein; ICU, intensive care unit; IL-6, interleukin-6; NIC, non-infectious conditions; SAB, Staphylococcus aureus bacteraemia; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SCOVID, suspected COVID-19; n/a, non-available data; WCC, white cell count.